Promising Penny Stocks To Research - June 11th

BigBear.ai, TeraWulf, Plug Power, Helius Medical Technologies, Nuwellis, NuCana, and NanoVibronix are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of very small companies that trade for less than $5 per share, often on over-the-counter markets rather than major exchanges. Because they tend to be thinly traded with limited financial disclosure, penny stocks are highly volatile and carry greater risk of price manipulation and steep losses. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

NYSE:BBAI traded up $0.05 during mid-day trading on Wednesday, reaching $3.82. The stock had a trading volume of 95,013,558 shares, compared to its average volume of 65,091,031. BigBear.ai has a 12 month low of $1.16 and a 12 month high of $10.36. The stock has a market capitalization of $1.11 billion, a PE ratio of -4.19 and a beta of 3.29. The company has a debt-to-equity ratio of 2.08, a current ratio of 2.06 and a quick ratio of 2.06. The stock has a 50-day simple moving average of $3.34 and a two-hundred day simple moving average of $3.93.

Read Our Latest Research Report on BBAI

TeraWulf (WULF)

Shares of WULF stock traded down $0.13 during trading hours on Wednesday, reaching $4.40. The company's stock had a trading volume of 40,088,183 shares, compared to its average volume of 41,198,773. TeraWulf has a fifty-two week low of $2.06 and a fifty-two week high of $9.30. The firm's 50 day simple moving average is $3.23 and its 200-day simple moving average is $4.50. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of -13.32 and a beta of 3.09.

Read Our Latest Research Report on WULF

Plug Power (PLUG)

Plug Power Inc. develops hydrogen and fuel cell product solutions in North America, Europe, Asia, and internationally. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenKey, an integrated turn-key solution for transitioning to fuel cell power.

Shares of Plug Power stock traded up $0.06 during trading on Wednesday, reaching $1.34. 119,356,285 shares of the company's stock were exchanged, compared to its average volume of 93,215,195. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.95 and a current ratio of 2.08. Plug Power has a 1-year low of $0.69 and a 1-year high of $3.34. The company has a market cap of $1.44 billion, a P/E ratio of -0.62 and a beta of 2.17. The firm's 50-day moving average price is $0.92 and its 200 day moving average price is $1.64.

Read Our Latest Research Report on PLUG

Helius Medical Technologies (HSDT)

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

NASDAQ HSDT traded up $0.43 during trading on Wednesday, hitting $1.28. 122,867,889 shares of the company's stock were exchanged, compared to its average volume of 801,646. The company has a market cap of $521,884.00, a PE ratio of -0.23 and a beta of 1.12. Helius Medical Technologies has a fifty-two week low of $0.75 and a fifty-two week high of $24.00. The stock's 50 day moving average price is $4.03 and its two-hundred day moving average price is $7.11.

Read Our Latest Research Report on HSDT

Nuwellis (NUWE)

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

Shares of Nuwellis stock traded up $0.13 during midday trading on Wednesday, hitting $0.37. 423,730,476 shares of the company traded hands, compared to its average volume of 3,077,321. The firm's fifty day moving average price is $0.87 and its 200-day moving average price is $1.08. The stock has a market cap of $1.61 million, a price-to-earnings ratio of 0.00 and a beta of 0.48. Nuwellis has a 12 month low of $0.21 and a 12 month high of $8.23.

Read Our Latest Research Report on NUWE

NuCana (NCNA)

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.

NuCana stock traded up $0.01 during mid-day trading on Wednesday, reaching $0.16. The company had a trading volume of 746,459,404 shares, compared to its average volume of 69,324,227. The business has a fifty day simple moving average of $0.39 and a 200 day simple moving average of $0.84. The company has a market cap of $891,917.00, a P/E ratio of -0.02 and a beta of 1.24. NuCana has a fifty-two week low of $0.03 and a fifty-two week high of $10.79.

Read Our Latest Research Report on NCNA

NanoVibronix (NAOV)

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

Shares of NAOV traded up $0.37 during trading hours on Wednesday, reaching $1.19. The stock had a trading volume of 96,817,326 shares, compared to its average volume of 3,513,481. NanoVibronix has a 12 month low of $0.67 and a 12 month high of $16.25. The stock has a market capitalization of $3.06 million, a PE ratio of -0.96 and a beta of 1.75. The company's 50-day moving average is $3.75 and its two-hundred day moving average is $4.77.

Read Our Latest Research Report on NAOV